Tolerability and Efficacy of Midostaurin to 10-day Decitabine in Unfit Adult AML and High Risk MDS Patients
Clinical trial NCT04097470 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04097470
- Sponsor
- Stichting Hemato-Oncologie voor Volwassenen Nederland
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-05
- Primary completion
- 2021-11-15
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.